(Q34280350)

English

The oral corticosteroid-sparing effect of omalizumab in children with severe asthma

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 August 2017

The oral corticosteroid-sparing effect of omalizumab in children with severe asthma (English)

1 reference

stated in

Europe PubMed Central

1 August 2017

0 references

Malcolm Brodlie

1

0 references

author name string

Michael C McKean

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

22685051

retrieved

1 August 2017

Samantha Moss

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

22685051

retrieved

1 August 2017

David A Spencer

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

22685051

retrieved

1 August 2017

language of work or name

English

0 references

publication date

9 June 2012

1 reference

stated in

Europe PubMed Central

1 August 2017

Archives of Disease in Childhood

1 reference

stated in

Europe PubMed Central

1 August 2017

97

1 reference

stated in

Europe PubMed Central

1 August 2017

7

1 reference

stated in

Europe PubMed Central

1 August 2017

604-609

1 reference

stated in

Europe PubMed Central

PubMed ID

22685051

retrieved

1 August 2017

Identifiers

DOI

10.1136/ARCHDISCHILD-2011-301570

1 reference

stated in

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

PubMed ID

22685051

retrieved

1 August 2017

ResearchGate publication ID

225287599

0 references

(Q34280350)

The oral corticosteroid-sparing effect of omalizumab in children with severe asthma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)